Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.3.1.51 (
HDR
)
605
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The SNP within intron 3 of the porcine
IGF2
gene (G3072A) plays an important role for muscle growth and fat deposition in pigs. In this study, the StCas9 derived from
Streptococcus thermophilus
together with the Drosha-mediated sgRNA-shRNA structure were combined to boost the G to A base editing on the
IGF2
SNP site, which we called "SNP editing." The codon-humanized StCas9 as we previously reported was firstly compared with the prevalently used SpCas9 derived from
Streptococcus pyogenes
using our idiomatic surrogate report assay, and the StCas9 demonstrated a comparable targeting activity. On the other hand, by combining shRNA with sgRNA, simultaneous gene silencing and genome targeting can be achieved. Thus, the novel
IGF2
.sgRNA-LIG4.shRNA-
IGF2
.sgRNA structure was constructed to enhance the sgRNA/Cas9-mediated
HDR
-based
IGF2
SNP editing by silencing the
LIG4
gene, which is a key molecule of the
HDR
's competitive NHEJ pathway. The sgRNA-shRNA/StCas9 all-in-one expression vector and the
IGF2
.sgRNA/StCas9 as control were separately used to transfect porcine PK15 cells together with an ssODNs donor for the
IGF2
SNP editing. The editing events were detected by the RFLP assay, Sanger sequencing as well as Deep-sequencing, and the Deep-sequencing results finally demonstrated a significant higher
HDR
-based editing efficiency (16.38%) for our sgRNA-shRNA/StCas9 strategy. In short, we achieved effective
IGF2
SNP editing by using the combined sgRNA-shRNA/StCas9 strategy, which will facilitate the further production of base-edited animals and perhaps extend for the gene therapy for the base correction of some genetic diseases.
...
PMID:sgRNA-shRNA Structure Mediated SNP Site Editing on Porcine
IGF2
Gene by CRISPR/StCas9. 3105 3